Loading

Benefits and Risks – Meniett Therapy

Benefits of Meniett Therapy

ent-meniett_tubeincase

Meniett therapy has been tested in many clinical studies

Meniett® therapy is a safe, simple, and effective treatment for the dizziness and vertigo symptoms of Ménière’s disease.1-12 The Meniett device can help you control your Ménière’s disease and get back to enjoying life. It’s small, portable, and easy to use. Meniett therapy just takes a few minutes each day.

Meniett therapy for Ménière’s disease has been developed and tested in nearly 30 years of clinical research.1-16 It’s a painless and minimally invasive type of Ménière’s disease therapy that the American Academy of Otolaryngology supports for certain cases of Ménière’s disease, especially after diet/medical treatment hasn’t worked.17

Meniett therapy doesn’t help every Ménière's disease patient. But if you use it exactly as prescribed, you’ll know in about 6 weeks if your Ménière's disease will respond to Meniett therapy. You can return the device for a refund within that timeframe if it doesn’t help you, and you can still have other Ménière’s disease treatments.

Risks of Meniett Therapy

ent-vent_tubesmall.jpg

A tiny vent tube, about 2 mm in size, allows the micropressure pulses to pass through the eardrum and reach the inner ear

The Meniett device has been tested in many clinical studies.1-12 Most patients use Meniett therapy with no negative side effects. A small computer in the device controls the micropressure pulses. The Meniett device also has a safety valve that limits the pressure delivered to your ear.

Before you begin Meniett therapy, you need a tiny vent tube placed in your eardrum. Vent tubes are often used for ear conditions and it’s a common procedure. For micropressure therapy, it allows the pressure pulses to pass through the eardrum to the inner ear.

There’s always a small risk of infection where the vent tube is inserted. Your doctor can tell you more about this risk and answer any questions you may have.

References

View full listView full list

  1. Dornhoffer JL, King D. The effect of the Meniett device in patients with Ménière's disease: long-term results. Otol Neurotol 2008; 29(6):868-74.
  2. Barbara M, Monini S, Chiappini I, Filipo R. Meniett therapy may avoid vestibular neurectomy in disabling Ménière's disease. Acta Otolaryngol 2007; 127(11):1136-1141.
  3. Mattox DE, Reichert M. Meniett device for Ménière's disease: use and compliance at 3 to 5 years. Otol Neurotol 2008; 29(1):29-32.
  4. Weining H, Fang L, Bo G, Jinmei Z. Clinical long-term effects of Meniett pulse generator for Ménière's disease. Acta Otolaryngol 2009; 129(8):819-825.
  5. Nabi S, Parnes LS. Bilateral Ménière’s disease. Curr Opin Otolaryngol Head Neck Surg 2009; 17:356-362.
  6. Thomsen J, Sass K, Ödkvist L, Arlinger S. Local over-pressure treatment reduces vestibular symptoms in patients with Ménière’s disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study. Otol Neurotol 2005; 26:68-73.
  7. Rajan GP, Din S, Atlas MD. Long-term effects of the Meniett device in Ménière’s disease: the Western Australian experience. J Laryngol Otol 2005; 119:391-395.
  8. Densert B, Sass K. Control of symptoms in patients with Ménière’s disease using middle ear applications: two years follow-up. Acta Otolaryngol 2001; 121(5):616-621.
  9. Gates GA, Green Jr. JD, Tucci DL, Telian SA. The effects of transtympanic micropressure treatment in people with unilateral Ménière’s disease. Arch of Oto – HNS 2004; 130(6):718-725.
  10. Gates GA, Verrall A, Green Jr. JD, Tucci DL, Telian SA. Meniett clinical trial: long-term follow-up. Arch Otolaryngol Head Neck Surg 2006; 132:1311-1316.
  11. Ödkvist LM, Arlinger S, Billermark E, Densert B, Lindholm S, Wallquist J. Effects of middle ear pressure changes on clinical symptoms in patients with Ménière’s disease: A clinical, multicenter, placebo-controlled study. Acta Otolaryngol Suppl 2000; 543: 99-101.
  12. Densert B, Densert O, Arlinger S, Sass K, Ödkvist LM. Immediate effects of middle ear pressure changes on the electrocochleographic recordings in patients with Ménière’s disease: A clinical placebo-controlled study. Am J Otol 1997; 18:726-733.
  13. Densert B, Densert O. Overpressure in treatment of Ménière’s disease. Laryngoscope 1982; 92:1285-1292.
  14. Densert B. Effects of overpressure on hearing function in Ménière’s disease. Acta Otolaryngol (Stockh) 1987; 103:32-42.
  15. Feijen RA, Segenhout JM, Wit HP, Albers FWJ. Monitoring inner ear pressure changes in normal guinea pigs induced by the Meniett 20. Acta Otolaryngol 2000; 804-809.
  16. Densert B, Sass K, Arlinger S. Short-term effects of induced middle ear pressure changes on the electrocochleogram in Ménière’s disease. Acta Otolaryngol (Stockh) 1995; 115: 732-737.
  17. Committee on Equilibrium of the American Academy of Otolaryngology–Head and Neck Surgery: Micropressure Therapy Policy Statement. March 2008.

Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.

Last updated: 19 Jul 2011

Section Navigation

Additional information

Contact Us

Customer Service
Medtronic
work (877) 966-3350 phone
work (866) 463-8726 fax